IRF9 and pulmonary arterial hypertension: Interferon Regulatory Factor 9 (IRF9) is upregulated in pulmonary artery smooth muscle cells in PAH and is related to mitochondrial dysfunction [110]; in LC, it is associated with reduced survival, promoting proliferation, migration, and tumor growth [111].